Best Peroxisome Proliferator Receptor alpha Agonist for coronary artery disease
3 Peroxisome Proliferator Receptor alpha Agonist drugs indicated for coronary artery disease, ranked by our independent rating. The current highest-rated is lopid. Compare them with all treatments for coronary artery disease or the full Peroxisome Proliferator Receptor alpha Agonist class. Not medical advice — always consult a professional.
Top peroxisome proliferator receptor alpha agonist for coronary artery disease: 1. Lopid · 2. Lipofen · 3. Gemfibrozil
| # | Drug | Rating | Type | Typical price | |
|---|---|---|---|---|---|
| 1 | Lopid | 56/100 | Prescription | $3 | View → |
| 2 | Lipofen | Not yet rated | Prescription | $3 | View → |
| 3 | Gemfibrozil | Not yet rated |
Full ranking · 3 drugs
Frequently asked
- What is the best peroxisome proliferator receptor alpha agonist for coronary artery disease?
- By our independent rating, lopid currently ranks highest among Peroxisome Proliferator Receptor alpha Agonist drugs used for coronary artery disease. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
- Which peroxisome proliferator receptor alpha agonist drugs treat coronary artery disease?
- pharmaranks lists 3 Peroxisome Proliferator Receptor alpha Agonist products indicated for coronary artery disease, per FDA drug-label data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.